シアノティック先天性心疾患における冠動脈の微循環
Eduard I Dedkov1, Joseph K Perloff, Robert J Tomanek
1Department of Anatomy and Cell Biology and Cardiovascular Center, University of Iowa Carver College of Medicine, Iowa City, USA.
Circulation
|July 13, 2006
まとめ
冠動脈微循環の改造は,シアノティック先天性心疾患における正常な血流の準備を維持します. 動脈管の直径の増加は,長さの密度の減少を補償し,重要な血流容量を維持します.
科学分野:
- 心血管研究 循環器科の研究
- ペディアトリック・カルディオロジー
- 血管生物学 血管生物学
背景:
- シアノティック先天性心疾患 (CCHD) は,基礎動脈冠動脈の血流が増加するが,正常な血流の準備がある.
- CCHDにおける血液動力学の変化にもかかわらず,フローリザーブを保持するメカニズムは完全に理解されていません.
- 冠動脈微循環の改造は,フロー・リザーブを維持する鍵であると仮定されています.
研究 の 目的:
- CCHDにおける冠動脈微循環の形態測定特性を調査する.
- 微循環器の改造がCCHDにおける冠動脈流量準備の保存を説明するかどうかを判断する.
- CCHDにおける微循環器の適応を,心室縮症の適応と比較する.
主な方法:
- アイゼンメンガー症候群 (CCHD),高縮異常心臓,高縮正常心臓,正常心臓の4つのグループから検死された心臓サンプルを形態測定分析.
- 滑らかな筋肉のアルファ-アクチンのための冠動脈動脈の免疫マーキング.
- 動脈管の寸法 (軸,面積,周長) を測定し,長さ,体積,表面密度などを計算する.
主要な成果:
- 血管長密度 (P=0.03) と直径 (P=0.03) において,グループ間の有意な差異が観察されました.
- アイゼンメンガー症候群の心臓は,大動脈の長さの密度が著しく低く,大動脈の平均直径 (34%) は,高縮性心臓 (P=0.03) と比較して著しく高かった.
- 動脈の体積密度は,すべてのグループで同様のままでした.
結論:
- 冠動脈微循環の改造は,CCHDにおけるフロー・リザーブを維持する主なメカニズムである.
- 動脈管の直径の増加は,動脈管の長さの密度の減少を補償する.
- この補償性動脈の膨張は,CCHDにおける正常な冠動脈流れの準備を維持するための主要な解剖学的基礎である.
さらに関連する動画
関連する概念動画
Coronary Circulation
9.9K
The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
9.9K
Physiology of the Heart: The Cardiac Cycle
15.9K
The cardiac cycle describes the events from one heartbeat to the next. It includes three main phases: diastole, atrial systole, and ventricular systole, all driven by changes in chamber pressures and the function of heart valves.
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...
15.9K
Mitral Stenosis I: Introduction
1.8K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805


